Humana Inc.
422.07USD
+1.1000 (+0.26%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on HUM.
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 92.9B | 106.4B | 117.8B | 129.7B | 162.7B | 168.7B |
| Q1 | 24.0B | 26.7B | 29.6B | 32.1B | 39.6B | — |
| Q2 | 23.7B | 26.7B | 29.5B | 32.4B | — | — |
| Q3 | 22.8B | 26.4B | 29.4B | 32.6B | 40.9B | — |
| Q4 | 22.4B* | 26.5B* | 29.2B* | 32.5B* | 41.3B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 22.08 | 20.00 | 9.98 | 9.84 | 9.16 | 17.09 |
| Q1 | 7.29 | 9.87 | 6.11 | 10.30 | 9.83 | — |
| Q2 | 5.48 | 7.66 | 5.62 | 4.51 | — | — |
| Q3 | 9.39 | 6.71 | 3.98 | 1.62 | -1.00 | — |
| Q4 | -.118* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| -4.35* |
| -5.73* |
| -6.59* |
| -7.86 |
| — |
Debt level and coverage